SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-20-139815
Filing Date
2020-12-28
Accepted
2020-12-28 16:48:08
Documents
12
Period of Report
2020-10-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2039383d1_8ka.htm   iXBRL 8-K/A 27270
  Complete submission text file 0001104659-20-139815.txt   203946

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA egrx-20201029.xsd EX-101.SCH 3184
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE egrx-20201029_lab.xml EX-101.LAB 34592
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE egrx-20201029_pre.xml EX-101.PRE 22709
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2039383d1_8ka_htm.xml XML 4196
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36306 | Film No.: 201418871
SIC: 2834 Pharmaceutical Preparations